Published date: 20 September 2024

This notice was replaced on 2 October 2024

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 2 October 2024)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Medical consumables - 33140000

Location of contract

LS1 4AP

Value of contract

£700,000

Procurement reference

CF-2597800D0O000000rwimUAA

Published date

20 September 2024

Closing date

18 September 2024

Closing time

12pm

Contract start date

1 October 2024

Contract end date

30 September 2025

Contract type

Service contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Contract for for the Spot-IT Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in 3 Screening laboratories.

Award information

Awarded date

17 September 2024

Contract start date

1 October 2024

Contract end date

30 September 2025

Total value of contract

£700,000

This contract was awarded to 1 supplier.

IMMUNOIVD AB

Address

Box 1140, SE-131 26 Nacka Strand, Sweden 13126

Reference

None

About the buyer

Contact name

Kaysha Maynard

Address

7 & 8 Wellington Place
Leeds
LS1 4AP
GB

Email

kaysha.maynard@nhs.net